[Form 4] JOHNSON & JOHNSON Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
JOHNSON & JOHNSON executive Kathryn E. Wengel reported an exercise-and-sell transaction in company stock. On June 11, 2026, she exercised 10,000 employee stock options with an exercise price of $115.67 per share and acquired the same number of common shares.
That same day, she sold 10,000 common shares in open-market transactions, with trades executed at prices between $240.14 and $240.19, according to a weighted-average price footnote. After these transactions, she directly owned 114,287.8735 shares of common stock and held 32,965 stock options outstanding.
She also reported indirect holdings of 281 shares through an ESOP position and 90 shares via a 401(k) plan as of the plan’s May 31, 2026 reporting date.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 10,000 shares ($2,411,500)
Net Sell
5 txns
Insider
Wengel Kathryn E
Role
EVP, Chief TO and Risk Officer
Sold
10,000 shs ($2.41M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Options (Right to Buy) | 10,000 | $0.00 | -- |
| Exercise | Common Stock | 10,000 | $115.67 | $1.16M |
| Sale | Common Stock | 10,000 | $241.15 | $2.41M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Employee Stock Options (Right to Buy) — 32,965 shares (Direct, null);
Common Stock — 124,287.874 shares (Direct, null);
Common Stock — 281 shares (Indirect, By ESOP)
Footnotes (1)
- This transaction was executed in multiple trades at prices ranging from $240.14 to $240.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (5/31/2026). Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (5/31/2026). Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
